Literature DB >> 32938783

Education Research: Effect of the COVID-19 pandemic on neurology trainees in Italy: A resident-driven survey.

Elena Abati1, Gianluca Costamagna2.   

Abstract

OBJECTIVE: To assess the effect of the coronavirus disease 2019 (COVID-19) outbreak on neurology resident training in Italy.
METHOD: We created a web-based survey regarding changes in clinical, research, and educational activity of neurology trainees in Italy during the COVID-19 pandemic and the preventive measures undertaken by local institutions to reduce the risk of contagion.
RESULTS: Seventy-nine residents working in Italy completed the survey. A total of 87.3% of trainees reported a substantial reduction in their neurologic duties since COVID-19 appeared in Italy, and 17.8% were also recruited or volunteered for COVID-19-dedicated wards. Likewise, more than 60% of trainees experienced a reduction or interruption in research activity. As regards the perceived effect of the COVID-19 outbreak on their neurologic training, almost 70% of surveyed trainees believe that the COVID-19 pandemic had or will have a negative effect on their formation as neurologists, for different reasons. Furthermore, trainees reported a consistent exposure (69.6%) to confirmed positive COVID-19 cases at work, with divergent surveillance and preventive measures taken by local institutions.
CONCLUSIONS: Overall, the survey shows that the COVID-19 pandemic in Italy has had a subjective negative effect on neurology residents on didactics, clinical, and research training as well as training abroad. The COVID-19 outbreak poses many challenges to academic institutions and training programs, and addressing these issues promptly is crucial to ensure continued quality of trainees' neurologic education. Sharing solutions and ideas among the international neurologic community might help neurology training programs worldwide to better counteract these problems.
© 2020 American Academy of Neurology.

Entities:  

Year:  2020        PMID: 32938783     DOI: 10.1212/WNL.0000000000010878

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Impact of Covid-19 on research and training in Parkinson's disease.

Authors:  Yi-Min Wan; Daniel J van Wamelen; Yue Hui Lau; Silvia Rota; Eng-King Tan
Journal:  Int Rev Neurobiol       Date:  2022-05-04       Impact factor: 4.280

2.  The experiences of early career geriatricians throughout Europe during the COVID-19 pandemic.

Authors:  Vojtech Mezera; Anne W Ekdahl; Dominic Bertschi; Maria Bonnici; Rui Buzaco; Santiago Cotobal Rodeles; Kseniia Eruslanova; Lubov Matchekhina; Laura Monica Perez Bazan; Itxaso Marin Epelde; Marina Kotsani; Grazia Daniela Femminella; Meltem Koca; Marian Dejaeger
Journal:  Eur Geriatr Med       Date:  2022-01-29       Impact factor: 1.710

3.  Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment.

Authors:  Urshila Durani; Ajay Major; Ana I Velazquez; Jori May; Marquita Nelson; Ze Zheng; Anurekha G Hall; Sara Taveras Alam; Robby Reynolds; J Colton Thompson; Ashok Kumbamu; Devika G Das; Martina C Murphy; Elizabeth Henry; Alfred Ian Lee; Ariela L Marshall; Ted Wun; Lachelle Dawn Weeks
Journal:  JCO Oncol Pract       Date:  2022-01-06

4.  A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region.

Authors:  Elena Abati; Leonardo Nelva Stellio; Arianna Manini; Francesco Moroni; Lorenzo Azzalini; Luz Maria Vilca
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

5.  The contribution of the Italian residents in neurology to the COVID-19 crisis: admirable generosity but neurological training remains their priority.

Authors:  Cristina Tassorelli; Vincenzo Silani; Alessandro Padovani; Paolo Barone; Paolo Calabresi; Paolo Girlanda; Leopnardo Lopiano; Luca Massacesi; Salvatore Monaco; Marco Onofrj; Gioacchino Tedeschi; Alfredo Berardelli
Journal:  Neurol Sci       Date:  2021-08-10       Impact factor: 3.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.